Food and health

Coffee consumption and the risk of lung cancer: an updated meta-analysis of epidemiological studies

Article metrics

Abstract

Background/Objectives:

Coffee is one of the most popularly consumed beverages worldwide. Many epidemiological studies have investigated the association between coffee consumption and lung cancer risk, but the results are inconsistent. Hence, we conducted a systematic analysis of relevant population-based studies to examine this association and derive a more precise estimation.

Subjects/Methods:

The Cochrane library, PubMed and Embase databases were searched to identify studies published through Mar 2015 that met the predetermined inclusion criterion. Seventeen studies (5 cohort and 12 case–control studies) involving 12 276 cases and 102 516 controls were included.

Results:

The summary odds ratio (OR) of lung cancer was 1.17 (95% confidence interval (CI): 1.03–1.33) for coffee drinkers compared with nondrinkers and 1.31 (95% CI: 1.11–1.55) for the highest category of coffee consumption compared with the lowest category. Compared with nondrinkers, the pooled ORs for lung cancer were 1.10 (95% CI: 0.92–1.31) for 1 cup per day, 1.10 (95% CI: 0.93–1.30) for 2–3 cups per day and 1.20 (95% CI: 1.02–1.39) for 3 cups per day. Further analysis showed that the ORs for hospital-based case–control studies, population-based case–control studies and prospective cohort studies were 1.36 (95% CI: 1.10–1.69), 0.99 (95% CI: 0.77–1.28) and 1.59 (95% CI: 1.26–2.00), respectively. Significant associations for high coffee intake with increased risk of lung cancer were observed in men (OR=1.41 95% CI: 1.21–1.63), but not in women (OR=1.16, 95% CI: 0.86–1.56), in American (OR=1.34 95% CI: 1.08–1.65) and Asian populations (OR=1.49 95% CI: 1.28–1.74), but not in European populations (OR=1.12, 95% CI: 0.74–1.67), and in smokers (OR=1.24, 95% CI: 1.00–1.54), but not in nonsmokers (OR=0.85, 95% CI: 0.64–1.11). Particularly over the last 5 years, studies have consistently indicated that lung cancer risk is significantly increased by 47% in the population with the highest category intake of coffee compared with that with the lowest category intake (OR=1.47, 95% CI: 1.21–1.79).

Conclusion:

The present study suggested that coffee intake was associated with an increased risk of lung cancer.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1
Figure 2
Figure 3

References

  1. 1

    Siegel R, Naishadham D, Jemal A . Cancer statistics. CA Cancer J Clin 2013; 63: 11–30.

  2. 2

    Gonzalez CA . The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2006; 9: 124–126.

  3. 3

    Abdull RAF, Noor NM . Cruciferous vegetables: dietary phytochemicals for cancer prevention. Asian Pac J Cancer Prev 2013; l14: 1565–1570.

  4. 4

    Dolara P, Bigagli E, Collins A . Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary. Eur J Nutr 2012; 51: 769–781.

  5. 5

    Gallicchio L, Boyd K, Matanoski G, Tao XG, Chen L, Lam TK et al. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 2008; 88: 372–383.

  6. 6

    Ludwig IA, Clifford MN, Lean ME, Ashihara H, Crozier A . Coffee: biochemistry and potential impact on health. Food Funct 2014; 5: 1695–1717.

  7. 7

    Shen T, Park YC, Kim SH, Lee J, Cho JY . Nuclear factor-kappaB/signal transducers and activators of transcription-1-mediated inflammatory responses in lipopolysaccharide-activated macrophages are a major inhibitory target of kahweol, a coffee diterpene. Biol Pharm Bull 2010; 33: 1159–1164.

  8. 8

    van Dam RM, Feskens EJ . Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002; 360: 1477–1478.

  9. 9

    Sapozhnikova Y . Development of liquid chromatography-tandem mass spectrometry method for analysis of polyphenolic compounds in liquid samples of grape juice, green tea and coffee. Food Chem 2014; 150: 87–93.

  10. 10

    O'Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ . Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 2013; 62: 1043–1051.

  11. 11

    Bakuradze T, Lang R, Hofmann T, Stiebitz H, Bytof G et al. Antioxidant effectiveness of coffee extracts and selected constituents in cell-free systems and human colon cell lines. Mol Nutr Food Res 2010; 54: 1734–1743.

  12. 12

    Glei M, Kirmse A, Habermann N, Persin C, Pool-Zobel BL . Bread enriched with green coffee extract has chemoprotective and antigenotoxic activities in human cells. Nutr Cancer 2006; 56: 182–192.

  13. 13

    Greenland S . Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1–30.

  14. 14

    Luqman M, Javed MM, Daud S, Raheem N, Ahmad J, Khan AU . Risk factors for lung cancer in the Pakistani population. Asian Pac J Cancer Prev 2014; 15: 3035–3039.

  15. 15

    Ganesh B, Sushama S, Monika S, Suvarna P . A case-control study of risk factors for lung cancer in Mumbai, India. Asian Pac J Cancer Prev 2011; 12: 357–362.

  16. 16

    Kubik A, Zatloukal P, Tomasek L, Dolezal J, Syllabova L, Kara J et al. A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma 2008; 55: 192–199.

  17. 17

    Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, Moysich KB . Associations between black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutr Cancer 2005; 52: 15–21.

  18. 18

    Takezaki T, Hirose K, Inoue M, Hamajima N, Yatabe Y et al. Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas. Br J Cancer 2001; 84: 1199–1206.

  19. 19

    Mendilaharsu M, De Stefani E, Deneo-Pellegrini H, Carzoglio JC, Ronco A . Consumption of tea and coffee and the risk of lung cancer in cigarette-smoking men: a case-control study in Uruguay. Lung Cancer 1998; 19: 101–107.

  20. 20

    Axelsson G, Liljeqvist T, Andersson L, Bergman B, Rylander R . Dietary factors and lung cancer among men in west Sweden. Int J Epidemiol 1996; 25: 32–39.

  21. 21

    Mettlin C . Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer 1989; 43: 608–612.

  22. 22

    Chiu YL, Wang XR, Qiu H, Yu IT . Risk factors for lung cancer: a case-control study in Hong Kong women. Cancer Causes Control 2010; 21: 777–785.

  23. 23

    Hu J, Mao Y, Dryer D, White K . Risk factors for lung cancer among Canadian women who have never smoked. Cancer Detect Prev 2002; 26: 129–138.

  24. 24

    Nyberg F, Agrenius V, Svartengren K, Svensson C, Pershagen G . Dietary factors and risk of lung cancer in never-smokers. Int J Cancer 1998; 78: 430–436.

  25. 25

    Bae JM, Li ZM, Shin MH, Kim DH, Lee MS, Ahn YO . Pulmonary tuberculosis and lung cancer risk in current smokers: the Seoul Male Cancer Cohort Study. J Korean Med Sci 2013; 28: 896–900.

  26. 26

    Khan MM, Goto R, Kobayashi K, Suzumura S, Nagata Y et al. Dietary habits and cancer mortality among middle aged and older Japanese living in hokkaido, Japan by cancer site and sex. Asian Pac J Cancer Prev 2004; 5: 58–65.

  27. 27

    Fu YY, Takezaki T, Tajima K . [Risk factors of lung cancer—follow-up studies in Nagoya Japan]. Zhonghua Liu Xing Bing Xue Za Zhi 1997; 18: 328–330.

  28. 28

    Stensvold I, Jacobsen BK . Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994; 5: 401–408.

  29. 29

    Nomura A, Heilbrun LK, Stemmermann GN . Prospective study of coffee consumption and the risk of cancer. J Natl Cancer Inst 1986; 76: 587–590.

  30. 30

    Sanikini H, Radoï L, Menvielle G, Guida F, Mattei F et al. Coffee consumption and risk of lung cancer: the ICARE study. Eur J Epidemiol 2015; 30: 81–85.

  31. 31

    Tomioka K, Saeki K, Obayashi K, Tanaka Y, Kurumatani N . Risk for lung cancer in workers exposed to benzidine and/or beta-naphthylamine: a protocol for systematic review and meta-analysis. Syst Rev 2014; 3: 112.

  32. 32

    Edwards JK, McGrath LJ, Buckley JP, Schubauer-Berigan MK, Cole SR, Richardson DB . Occupational radon exposure and lung cancer mortality: estimating intervention effects using the parametric g-formula. Epidemiology 2014; 25: 829–834.

  33. 33

    Zendehdel R, Tayefeh-Rahimian R, Kabir A . Chronic exposure to chlorophenol related compounds in the pesticide production workplace and lung cancer: a meta-analysis. Asian Pac J Cancer Prev 2014; 15: 5149–5153.

  34. 34

    Cardaba AM, Munoz MMF, Armentia MA, Alonso CM, Carreras VF, Almaraz GA . Health impact assessment of air pollution in Valladolid, Spain. BMJ Open 2014; 4: e005999.

  35. 35

    Hong YS, Song KH, Chung JY . Health effects of chronic arsenic exposure. J Prev Med Public Health 2014; 47: 245–252.

  36. 36

    Steinmaus C, Ferreccio C, Acevedo J, Yuan Y, Liaw J et al. Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure. Cancer Epidemiol Biomarkers Prev 2014; 23: 1529–1538.

  37. 37

    Tang N, Wu Y, Ma J, Wang B, Yu R . Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer 2010; 67: 17–22.

  38. 38

    Sang LX, Chang B, Li XH, Jiang M . Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol 2013; 13: 34.

  39. 39

    Tian C, Wang W, Hong Z, Zhang X . Coffee consumption and risk of colorectal cancer: a dose-response analysis of observational studies. Cancer Causes Control 2013; 24: 1265–1268.

  40. 40

    Lu Y, Zhai L, Zeng J, Peng Q, Wang J, Deng Y et al. Coffee consumption and prostate cancer risk: an updated meta-analysis. Cancer Causes Control 2014; 25: 591–604.

  41. 41

    Cao S, Liu L, Yin X, Wang Y, Liu J, Lu Z . Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis 2014; 35: 256–261.

  42. 42

    Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N . Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol 2014; 180: 763–775.

Download references

Acknowledgements

This work was supported by a research grant from the National Natural Science Foundation of China (81001197, Su YX, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and National Key Specialty Construction of Clinical Projects (#2013-544). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The ethics committee of the Children’s Hospital of Chongqing Medical University approved the study.

Author information

Correspondence to Y Su.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading